This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, National University of Singapore, Sengenics Corporation Pte Ltd. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,562 
1 out of 857 
1 out of 2 Years Active: 2025-2026
Title: Arif Anwar: Innovator in Health Status Identification
Introduction
Arif Anwar is a notable inventor based in Kuala Lumpur, Malaysia. He has made significant contributions to the field of health diagnostics, particularly focusing on the elderly population. His innovative approach utilizes immunological biomarkers to assess health status, showcasing his commitment to improving healthcare outcomes.
Latest Patents
Arif Anwar holds a patent for a method titled "Identification of health status in the elderly using immunological biomarkers." This patent describes a technique for determining the health status of elderly individuals by testing samples for the presence of specific biomarkers. The biomarkers include autoantibodies to various antigens, such as MAPK13, CD96, FKBP3, PPM1A, PHLDA1, GLRX3, FEN1, and AURKA. The method categorizes health status into three groups: healthy, intermediate health, and unhealthy, based on the presence of these biomarkers.
Career Highlights
Throughout his career, Arif Anwar has worked with reputable organizations, including Sengenics Corporation Pte Ltd and the Agency for Science, Technology and Research. His experience in these institutions has allowed him to develop and refine his innovative ideas in health diagnostics.
Collaborations
Arif has collaborated with notable colleagues, including Jonathan Michael Blackburn and Nurul H Rutt. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Arif Anwar's work in identifying health status through immunological biomarkers represents a significant advancement in healthcare for the elderly. His innovative methods and collaborations highlight his dedication to improving health diagnostics and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile